Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Naloxone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4 Pain 2 Bronchiolitis Obliterans Syndrome 2 Constipation 1 Cancer Pain 1

Interventions

Morphine 15 Oxycodone 12 Methadone 7 Fentanyl 6 Lidocaine 5 Acetaminophen 5 nabiximols 4 Ethanol 4 resiniferatoxin 3 Transcutaneous Electric Nerve Stimulation 3 Hydromorphone 3 Buprenorphine 3 Acupuncture Therapy 3 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 tanezumab 1 rofecoxib 1 oxycodone naloxone combination 1 naloxegol 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01313780 2017-12-22

TOP

Mundipharma Korea Ltd

Phase 4 Completed

128 enrolled 8 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡